- Natural MedCo Ltd (NMC) has entered into an agreement with Cannamedical Pharma® GmbH
- NMC will export medical graded dried cannabis flower to CM
- CM will distribute medical graded cannabis products in Germany
- Cannamedical Pharma specializes in the import and distribution of medicinal cannabis to pharmacies and clinical facilities in the EU
- Eve & Co, through its wholly-owned subsidiary Natural MedCo, holds cultivation and processing licenses for the production and sale of cannabis products
- Eve & Co Incorporated (EVE) opened trading at C$0.215 per share
Eve & Co. (EVE) wholly-owned subsidiary, Natural MedCo Ltd (NMC) has entered into an agreement with Cannamedical Pharma® GmbH (CM).
NMC will export medical graded dried cannabis flower to CM and CM will distribute medical-grade cannabis products in Germany.
Cannamedical Pharma specializes in the import and distribution of medicinal cannabis to pharmacies and clinical facilities in the European Union.
“We are very pleased to be able to work with one of the leading medical cannabis wholesalers in the EU for the potential supply of up to approximately $7M of cannabis product over the next two years. CM is committed to improving patients’ quality of life, and as this parallels our directive, we are pleased to assist CM in this goal. This agreement is one of the ten supply agreements we have with buyers in Germany and forms part of our strategy to provide significant supply in the EU,” commented Melinda Rombouts, President and Chief Executive Officer at Eve & Co.
Eve & Co, through its wholly-owned subsidiary Natural MedCo Ltd., holds cultivation and processing licenses under the Cannabis Act (Canada) for the production and sale of various cannabis products, including dried cannabis, cannabis plants and extraction of cannabis oil and has received EU GMP certification.
Eve & Co Incorporated (EVE) opened trading at C$0.215 per share.
